APEN
Price:
$10
Market Cap:
$579.72M
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX ...[Read more]
Industry
Medical - Devices
IPO Date
2005-04-21
Stock Exchange
NASDAQ
Ticker
APEN
According to Apollo Endosurgery, Inc.’s latest financial reports and current stock price. The company's current ROE is -84.92%. This represents a change of 264.06% compared to the average of -23.32% of the last 4 quarters.
The mean historical ROE of Apollo Endosurgery, Inc. over the last ten years is -236.57%. The current -84.92% ROE has changed -64.11% with respect to the historical average. Over the past ten years (40 quarters), APEN's ROE was at its highest in in the September 2021 quarter at 7.24%. The ROE was at its lowest in in the December 2019 quarter at -338.95%.
Average
-236.57%
Median
-100.86%
Minimum
-1292.13%
Maximum
-40.31%
Discovering the peaks and valleys of Apollo Endosurgery, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 713.60%
Maximum Annual ROE = -40.31%
Minimum Annual Increase = -87.97%
Minimum Annual ROE = -1292.13%
Year | ROE | Change |
---|---|---|
2022 | -122.23% | 203.25% |
2021 | -40.31% | -87.97% |
2020 | -334.93% | -74.08% |
2019 | -1292.13% | 713.60% |
2018 | -158.82% | 190.45% |
2017 | -54.68% | -43.66% |
2016 | -97.05% | 2.11% |
2015 | -95.05% | -9.19% |
2014 | -104.67% | 58.94% |
2013 | -65.86% | 257.58% |
The current ROE of Apollo Endosurgery, Inc. (APEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-165.82%
5-year avg
-389.68%
10-year avg
-236.57%
Apollo Endosurgery, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apollo Endosurgery, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apollo Endosurgery, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Apollo Endosurgery, Inc.'s ROE?
How is the ROE calculated for Apollo Endosurgery, Inc. (APEN)?
What is the highest ROE for Apollo Endosurgery, Inc. (APEN)?
What is the 3-year average ROE for Apollo Endosurgery, Inc. (APEN)?
What is the 5-year average ROE for Apollo Endosurgery, Inc. (APEN)?
How does the current ROE for Apollo Endosurgery, Inc. (APEN) compare to its historical average?